000 | 05981cam a2200829Ii 4500 | ||
---|---|---|---|
001 | ocn947837521 | ||
003 | OCoLC | ||
005 | 20220712031814.0 | ||
006 | m o d | ||
007 | cr cnu|||unuuu | ||
008 | 160426s2016 nyua ob 001 0 eng d | ||
040 |
_aN$T _beng _erda _epn _cN$T _dN$T _dYDXCP _dOCLCF _dEBLCP _dSNK _dDKU _dAUW _dIGB _dD6H _dVTS _dAGLDB _dG3B _dS8J _dS9I _dSTF _dOCLCQ _dOCLCO |
||
020 |
_a9781634842792 _qelectronic bk. |
||
020 |
_a1634842790 _qelectronic bk. |
||
020 | _z9781634842785 | ||
029 | 1 |
_aAU@ _b000062420142 |
|
035 | _a(OCoLC)947837521 | ||
050 | 4 | _aRC280.B7 | |
072 | 7 |
_aHEA _x039000 _2bisacsh |
|
072 | 7 |
_aMED _x014000 _2bisacsh |
|
072 | 7 |
_aMED _x022000 _2bisacsh |
|
072 | 7 |
_aMED _x112000 _2bisacsh |
|
072 | 7 |
_aMED _x045000 _2bisacsh |
|
082 | 0 | 4 |
_a616.99481 _223 |
049 | _aMAIN | ||
245 | 0 | 0 |
_aOligodendrogliomas (ODs) : _bdiagnosis, outcomes and prognosis / _cChad Reeves, editor. |
246 | 3 | 0 | _aOligodendrogliomas |
264 | 1 |
_aNew York : _bNova Science Publishers, Inc., _c[2016] |
|
300 |
_a1 online resource : _billustrations. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 | _aCancer etiology, diagnosis, and treatments | |
500 | _a"Nova Biomedical." | ||
504 | _aIncludes bibliographical references and index. | ||
588 | 0 | _aOnline resource; title from PDF title page (EBSCO, viewed May 9, 2016). | |
505 | 0 | _aOLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; OLIGODENDROGLIOMAS (ODS) DIAGNOSIS, OUTCOMES AND PROGNOSIS ; CONTENTS ; PREFACE ; Chapter 1 PATHOLOGY, MOLECULAR MECHANISMS AND CLINICAL REFERENCES OF OLIGODENDROGLIOMAS ; ABSTRACT; 1. INTRODUCTION; 1.1. The Origin of Oligodendroglioma; 1.2. Epidemiology; 1.3. Clinical Features; 1.4. Neuroradiological Features; 2. PATHOLOGY ; 2.1. Macroscopic Appearance ; 2.2. Microscopic Appearance ; OII ; OIII ; OAII ; OAIII; GBMO; 2.3. Microglia/Macrophages ; 2.4. Differential Diagnosis and Prognosis | |
505 | 8 | _a3. MOLECULAR GENETICS WITH REFERENCE TO DIFFERENTIAL DIAGNOSIS AND PROGNOSIS 3.1. 1p/19q Chromosomal Status ; 3.2. Mechanism of the Combined Loss of Chromosomes 1p and 19q ; 3.3. Methods for the Detection of 1p/19q Chromosomal Status ; 3.4. Candidate Tumor Suppressor Genes (TSGs) on 1p and 19q ; 3.5. IDH1/2 Mutations ; 3.6. Telomerase Reverse Transcriptase (TERT) Promoter Mutations ; 3.7. ATRX Mutations ; 3.8. CIC and FUBP1 Mutations ; 3.9. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Hypermethylation and G-CIMP ; 3.10. Epithelial Membrane Protein 3 (EMP3) | |
505 | 8 | _a3.11. Anaplastic Oligodendroglioma 3.12. Pediatric Oligodendroglioma ; 3.13. GBMO ; 3.14. Timing and Relationships with Gliomagenesis ; 4. MICRORNAS (MIRNAS) ; 5. TREATMENT ; 6. PROGNOSIS ; CONCLUSION; ACKNOWLEDGMENT ; REFERENCES ; Chapter 2 MOLECULAR MARKERS OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION ; EPIDEMIOLOGY AND AETIOLOGY ; TUMOUR SIGNS AND SYMPTOMS ; TREATMENT OF OLIGODENDROGLIAL TUMOURS ; HISTOPATHOLOGY AND NEUROONCOLOGY ; THE IMPORTANCE OF MOLECULAR MARKERS ; Chromosomes 1 and 19 and the Prognostic and Diagnostic Value of 1p and 19q Abnormalities ; MGMT Mutation | |
505 | 8 | _aHypermethylation Mutations in p53Gene ; Growth Factors and Other Genetic Abnormalities ; CONCLUSION; REFERENCES; Chapter 3 OLIGODENDROGLIOMA LOOK-ALIKES: THE HISTOPATHOLOGIC DIFFERENTIAL DIAGNOSIS ; ABSTRACT ; INTRODUCTION ; WHAT DOES OLIGODENDROGLIOMA LOOK LIKE? ; DIFFUSE ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; OLIGOASTROCYTOMA/MIXED GLIOMA VERSUS OLIGODENDROGLIOMA ; PILOCYTIC ASTROCYTOMA VERSUS OLIGODENDROGLIOMA ; PAPILLARY GLIONEURONAL TUMOR VERSUS OLIGODENDROGLIOMA; DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR VERSUS OLIGODENDROGLIOMA ; GANGLIOGLIOMA VERSUS OLIGODENDROGLIOMA | |
505 | 8 | _aCENTRAL NEUROCYTOMA VERSUS OLIGODENDROGLIOMA CLEAR CELL EPENDYMOMA VERSUS OLIGODENDROGLIOMA ; ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE VERSUS OLIGODENDROGLIOMA ; INFLAMMATORY-RELATED LESIONS VERSUS OLIGODENDROGLIOMAS ; CONCLUSION; REFERENCES ; Chapter 4 LESSONS LEARNED FROM AWAKE BRAIN FUNCTION MAPPING IN AGGRESSIVE MULTIMODAL RESECTION OF OLIGODENDROGLIOMAS ; ABSTRACT ; INTRODUCTION; ROLE FOR SURGERY ; ONCOFUNCTIONAL BALANCE ; MAPPING; ANATOMO-FUNCTIONAL VARIABILITY ; PLASTICITY; SELECTED CASES ; ALTERNATIVES TO INTRA-OPERATIVE MAPPING ; SURGICAL ADJUVANTS | |
590 |
_aeBooks on EBSCOhost _bEBSCO eBook Subscription Academic Collection - Worldwide |
||
650 | 0 |
_aOligodendroglia. _91107577 |
|
650 | 0 |
_aGliomas. _9297600 |
|
650 | 0 |
_aNervous system _xTumors. _91097135 |
|
650 | 0 |
_aBrain _xTumors. _9208833 |
|
650 | 2 |
_aOligodendroglia _91107577 |
|
650 | 2 |
_aGlioma _9917963 |
|
650 | 2 |
_aNervous System Neoplasms _91107578 |
|
650 | 2 |
_aBrain Neoplasms _9917964 |
|
650 | 6 |
_aOligodendroglie. _91107579 |
|
650 | 6 |
_aGliome. _9917965 |
|
650 | 6 |
_aSystème nerveux _xTumeurs. _91107580 |
|
650 | 6 |
_aCerveau _xTumeurs. _9917966 |
|
650 | 7 |
_aHEALTH & FITNESS / Diseases / General _2bisacsh _992207 |
|
650 | 7 |
_aMEDICAL / Clinical Medicine _2bisacsh _992208 |
|
650 | 7 |
_aMEDICAL / Diseases _2bisacsh _992209 |
|
650 | 7 |
_aMEDICAL / Evidence-Based Medicine _2bisacsh _992210 |
|
650 | 7 |
_aMEDICAL / Internal Medicine _2bisacsh _992211 |
|
650 | 7 |
_aBrain _xTumors. _2fast _0(OCoLC)fst00837679 _9208833 |
|
650 | 7 |
_aGliomas. _2fast _0(OCoLC)fst00943446 _9297600 |
|
650 | 7 |
_aNervous system _xTumors. _2fast _0(OCoLC)fst01036147 _91097135 |
|
650 | 7 |
_aOligodendroglia. _2fast _0(OCoLC)fst01045445 _91107577 |
|
655 | 4 | _aElectronic books. | |
700 | 1 |
_aReeves, Chad, _eeditor. _91107581 |
|
830 | 0 | _aCancer etiology, diagnosis, and treatments. | |
856 | 4 | 0 | _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1226077 |
938 |
_aProQuest Ebook Central _bEBLB _nEBL4586556 |
||
938 |
_aEBSCOhost _bEBSC _n1226077 |
||
938 |
_aYBP Library Services _bYANK _n12759158 |
||
994 |
_a92 _bINOPJ |
||
999 |
_c2800334 _d2800334 |